Concern has been raised towards the use of anti-TNF therapy in patients with RA-ILD, since cases of disease progression and safety issues have been reported but the clinical relevance and prevalence of these observations require further data-based confirmation (202). This evidence concerns the gene TNF and rheumatoid arthritis.